BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27607234)

  • 21. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
    Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
    Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
    Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
    Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xeroderma pigmentosum: low prevalence of germline XPA mutations in a Brazilian XP population.
    Santiago KM; França de Nóbrega A; Rocha RM; Rogatto SR; Achatz MI
    Int J Mol Sci; 2015 Apr; 16(4):8988-96. PubMed ID: 25913378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 10-year follow-up of a child with mild case of xeroderma pigmentosum complementation group D diagnosed by whole-genome sequencing.
    Ono R; Masaki T; Mayca Pozo F; Nakazawa Y; Swagemakers SM; Nakano E; Sakai W; Takeuchi S; Kanda F; Ogi T; van der Spek PJ; Sugasawa K; Nishigori C
    Photodermatol Photoimmunol Photomed; 2016 Jul; 32(4):174-80. PubMed ID: 26993158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients.
    Tamhankar PM; Iyer SV; Ravindran S; Gupta N; Kabra M; Nayak C; Kura M; Sanghavi S; Joshi R; Chennuri VS; Khopkar U
    Indian J Dermatol Venereol Leprol; 2015; 81(1):16-22. PubMed ID: 25566891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions.
    Sethi M; Lehmann AR; Fawcett H; Stefanini M; Jaspers N; Mullard K; Turner S; Robson A; McGibbon D; Sarkany R; Fassihi H
    Br J Dermatol; 2013 Dec; 169(6):1279-87. PubMed ID: 23889214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
    Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA
    Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in the XPD gene in xeroderma pigmentosum group D cell strains: confirmation of genotype-phenotype correlation.
    Kobayashi T; Uchiyama M; Fukuro S; Tanaka K
    Am J Med Genet; 2002 Jul; 110(3):248-52. PubMed ID: 12116233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of mutations in XPD(ERCC2) on pregnancy and prenatal development in mothers of patients with trichothiodystrophy or xeroderma pigmentosum.
    Tamura D; Khan SG; Merideth M; DiGiovanna JJ; Tucker MA; Goldstein AM; Oh KS; Ueda T; Boyle J; Sarihan M; Kraemer KH
    Eur J Hum Genet; 2012 Dec; 20(12):1308-10. PubMed ID: 22617342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carrier frequency of the recurrent mutation c.1643_1644delTG in the XPC gene and birth prevalence of the xeroderma pigmentosum in Morocco.
    Doubaj Y; Laarabi FZ; Elalaoui SC; Barkat A; Sefiani A
    J Dermatol; 2012 Apr; 39(4):382-4. PubMed ID: 22211393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene.
    Broughton BC; Berneburg M; Fawcett H; Taylor EM; Arlett CF; Nardo T; Stefanini M; Menefee E; Price VH; Queille S; Sarasin A; Bohnert E; Krutmann J; Davidson R; Kraemer KH; Lehmann AR
    Hum Mol Genet; 2001 Oct; 10(22):2539-47. PubMed ID: 11709541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rare exon 10 deletion in POLH gene in a family with xeroderma pigmentosum variant correlating with protein expression by immunohistochemistry.
    Borroni RG; Diegoli M; Grasso M; Concardi M; Agozzino M; Vignini M; Arbustini E
    G Ital Dermatol Venereol; 2020 Jun; 155(3):349-354. PubMed ID: 32635709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and Mutational Spectrum of Xeroderma Pigmentosum in Egypt: Identification of Six Novel Mutations and Implications for Ancestral Origins.
    Rabie E; Amr K; Zada S; El-Sayed H; El Darouti M; El-Kamah G
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33672602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.
    Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M
    Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Iberian legacy into a young genetic xeroderma pigmentosum cluster in central Brazil.
    Castro LP; Sahbatou M; Kehdy FSG; Farias AA; Yurchenko AA; de Souza TA; Rosa RCA; Mendes-Junior CT; Borda V; Munford V; Zanardo ÉA; Chehimi SN; Kulikowski LD; Aquino MM; Leal TP; Tarazona-Santos E; Chaibub SC; Gener B; Calmels N; Laugel V; Sarasin A; Menck CFM
    Mutat Res Genet Toxicol Environ Mutagen; 2020 Apr; 852():503164. PubMed ID: 32265042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The experience of a Tunisian referral centre in prenatal diagnosis of Xeroderma pigmentosum.
    Messaoud O; Ben Rekaya M; Jerbi M; Ouertani I; Kefi R; Laroussi N; Bouyacoub Y; Benfadhel S; Yacoub-Youssef H; Boubaker S; Zghal M; Mrad R; Amouri A; Abdelhak S
    Public Health Genomics; 2013; 16(5):251-4. PubMed ID: 24021614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xeroderma pigmentosum.
    Lehmann AR; McGibbon D; Stefanini M
    Orphanet J Rare Dis; 2011 Nov; 6():70. PubMed ID: 22044607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
    Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
    Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with Xeroderma Pigmentosum: a case report and review of the genetic variants reported in XPC.
    Rivera-Begeman A; McDaniel LD; Schultz RA; Friedberg EC
    DNA Repair (Amst); 2007 Jan; 6(1):100-14. PubMed ID: 17079196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Xeroderma pigmentosum: children of the moon].
    Herouy Y; Krutmann J; Norgauer J; Schöpf E
    J Dtsch Dermatol Ges; 2003 Mar; 1(3):191-8. PubMed ID: 16285494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.